Vertex Pharmaceuticals (VRTX)

Total Assets

$27.42B

Quarterly · Period ending: · USD

VRTX logo

VRTX Total Assets

Latest reported$27.42B
VRTX Quarterly Total Assets ($9.20M → $27.42B)
High-resolution chart · PNG

VRTX total assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Total Assets — Quarterly (USD)
Period endingTotal Assets (USD)
27,423,300,000
26,484,400,000
26,142,800,000
24,862,300,000
24,036,700,000
22,880,500,000
22,533,200,000
22,240,200,000
20,132,100,000
23,917,400,000
22,730,200,000
21,726,200,000
20,349,200,000
18,974,200,000
18,150,900,000
16,706,400,000
15,582,200,000
14,256,100,000
13,432,500,000
12,618,745,000
12,221,686,000
12,115,059,000
11,751,808,000
11,301,633,000
10,216,367,000
8,893,201,000
8,318,465,000
7,514,553,000
7,033,471,000
6,543,114,000
6,245,898,000
4,620,840,000
4,335,386,000
3,952,974,000
3,546,014,000
3,198,325,000
3,285,594,000
2,946,703,000
2,893,785,000
2,604,838,000
2,548,982,000
2,487,906,000
2,497,045,000
2,433,993,000
2,374,073,000
2,165,827,000
2,336,309,000
2,406,086,000
2,117,820,000
2,197,108,000
2,319,041,000
2,582,755,000
2,584,329,000
2,392,234,000
2,759,288,000
2,718,823,000
2,604,856,000
2,345,843,000
2,204,280,000
2,091,998,000
1,763,100,000
1,538,487,000
1,725,446,000
1,888,829,000
1,654,202,000
1,770,302,000
1,955,488,000
1,573,491,000
1,439,876,000
1,565,883,000
980,479,000
1,067,554,000
970,805,000
889,505,000
601,477,000
655,148,000
761,070,000
835,095,000
921,579,000
902,111,000
625,478,000
524,658,000
548,998,000
550,575,000
596,903,000
484,229,000
545,453,000
574,362,000
624,051,000
669,188,000
724,411,000
742,676,000
787,456,000
840,306,000
815,720,000
831,069,000
860,474,000
875,510,000
925,131,000
922,370,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.